ImmuneOncia aims to develop immuno-oncology therapeutics

to transform the standard of care in cancer treatment

  • IR/PR
  • Disclosures

Disclosures

Submission Date Disclosure Title Author
2026-02-23 Notice on Investor Relations 이뮨온시아
2026-02-09 Registration Statement (Equity securities) 이뮨온시아
2026-02-06 Decision on Capital Increase with Consideration 이뮨온시아
2026-02-06 Resolutions for Convocation of General Meeting of Shareholders 이뮨온시아
2026-02-06 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) 이뮨온시아
2025-12-16 Closure of Register of Shareholders or Designation of Record Date 이뮨온시아
2025-11-28 Response to Request for Inquired Disclosure (Significant Change in Stock Trading Activities) : Denial 이뮨온시아
2025-11-27 Request for Inquired Disclosure (Significant Market Fluctuations) 코스닥시장본부
2025-11-14 Quarterly Report (2025.09) 이뮨온시아
2025-08-14 Semi-annual Report (2025.06) 이뮨온시아
1 2 3